MONDAY, 23 MAY
07:30 – 08:15 | Attilio Maseri – Blue room
BREAKFAST SESSION* ORGANIZED AND SUPPORTED BY NOVARTIS PHARMA AG
Beyond the data: what drives clinical decisions for LDL-C
management?
Chair: Michal Vrablik, Czech Republic
Managing LDL-C through a clinician’s lens
Michal Vrablik, Czech Republic
Managing LDL-C through a behavioral lens
Matthew Willcox, United Stated
Managing LDL-C through a practical lens: A case study
Ingo Hilgendorf, Germany
Panel discussion and Q&A
All Faculty
MONDAY, 23 MAY
13:30 – 15:15 | Attilo Maseri – Blue room
SPECIAL LECTURE* ORGANIZED AND SUPPORTED BY NOVARTIS PHARMA AG
Detecting elevated lipoprotein(a) and addressing the ASCVD risks
Chair: Alberico Catapano, Italy
Lp(a): What we need to know
Alberico Catapano, Italy
Why measure Lp(a) and how do I interpret it?
Florian Kronenberg, Austria
Elevated Lp(a) in clinical practice- Implications for managing
our patients
Elisabeth Steinhagen-Thiessen, Germany
Q&A
All Faculty
*These sessions are not included in the main conference CME/CPD credit.
